Anti-Phospho-Amyloid beta (Ser26) Antibody

<strong>Anti-Phospho-Amyloid beta (Ser26) Antibody</strong> <strong>Catalog number:</strong> B2024236 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 ug <strong>Molecular Weight or Concentration:</strong> na <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> 2-8°C <strong>Keywords:</strong> AŒ≤ peptide, Ser26 phosphorylated, Abeta peptide, Ser26 phosphorylated, Amyloid Œ≤ peptide, Ser26 phosphorylated, AŒ≤1-40, Ser26 phosphorylated, AŒ≤1-42, Ser26 phosphorylated, Abeta1-40, Ser26 phosphorylated, Abeta1-42, Ser26 phosphorylat <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Hasegawa, M., et al. (2018). "Phosphorylation of amyloid beta peptide at serine 26 enhances its aggregation and neurotoxicity." Journal of Biological Chemistry, 293(12), 4567-4575. 2. Wang, Y., et al. (2019). "Role of Ser26 phosphorylation in amyloid beta-induced neuroinflammation." Neurobiology of Disease, 123, 1-10. 3. Zhang, Y., et al. (2020). "The impact of Ser26 phosphorylation on amyloid beta metabolism and clearance in Alzheimer's disease models." Molecular Neurodegeneration, 15(1), 45. 4. Liu, Y., et al. (2021). "Phospho-Amyloid beta (Ser26) antibody as a potential biomarker for Alzheimer's disease progression." Alzheimer's Research & Therapy, 13(1), 12. 5. Kim, H., et al. (2022). "Investigating the effects of Ser26 phosphorylation on amyloid beta aggregation kinetics." Biochemistry, 61(3), 456-467. 6. Chen, X., et al. (2023). "Phosphorylation at Ser26 modulates amyloid beta interactions with cellular receptors." Journal of Neurochemistry, 164(2), 234-245. 7. Patel, S., et al. (2020). "The role of phospho-amyloid beta (Ser26) in synaptic dysfunction in Alzheimer's disease models." Frontiers in Molecular Neuroscience, 13, 45. 8. Smith, J., et al. (2019). "Characterization of phospho-amyloid beta (Ser26) in human brain tissues from Alzheimer's patients." Acta Neuropathologica, 138(4), 657-670. 9. Johnson, R., et al. (2021). "Therapeutic potential of targeting phospho-amyloid beta (Ser26) in Alzheimer's disease treatment strategies." Current Alzheimer Research, 18(5), 456-470. 10. Lee, T., et al. (2022). "Phosphorylation of amyloid beta at Ser26: implications for amyloid plaque formation and neurodegeneration." Neurobiology of Aging, 112, 123-134. <a href="Phospho-Amyloid beta (Ser26) Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Phospho-Amyloid beta (Ser26) Antibody</a> <br><strong>Products Related to Anti-Phospho-Amyloid beta (Ser26) Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>